Fig. 2From: Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, UgandaThe risk categories of clinically significant drug-drug interaction among cancer patients at the cancer unit, Uganda. c- Risk rating that requires therapy monitoring; d – Risk rating that requires therapy modification; x- Risk rating that requires therapy avoidanceBack to article page